Biotechnology

Biotechnology Industry Market Research Reports

Biotechnology Industry Market Research Reports, Analysis and Trends

 

Publication Single User License (PDF) Price
New Phase of Mab Biosimilar knocks the door Biosimilar Opportunities In Japan

New Phase of Mab Biosimilar knocks the door Biosimilar Opportunities In Japan

Date Published: Jan 20 2015
The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is faster than U.S. in adapting to biosimilar use. After nine years of continuous efforts by the JP government to promote increased use of generics (started in 2006 by launching various benefits for GE use at Pharmacy, hospital level) – now in 2014, Generic penetration of small molecules is changing the trend line and moving towards faster market penetration.
$4,000.00
Competitor Analysis: Nonalcoholic Steatohepatitis (NASH) – Novel Drug Candidates

Competitor Analysis: Nonalcoholic Steatohepatitis (NASH) – Novel Drug Candidates

Date Published: Jan 14 2015
The Competitive Intelligence report about Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates provides a competitor analysis in the development pipeline of novel therapeutics for treatment of NASH. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
 
$249.00
Antibiotics Partnering Terms and Agreements

Antibiotics Partnering Terms and Agreements

Date Published: Jan 1 2015
The Antibiotics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibiotic partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

The Antibiotics Partnering Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.
$1,995.00
U.S. Orthopedic Biomaterials Market - 2015

U.S. Orthopedic Biomaterials Market - 2015

Date Published: Jan 1 2015
The fastest growing segments involve stem cells, namely the segments for stem cell bone grafts and concentrated bone marrow. The products within these markets offer the greatest regenerative potential for healing bone.
 
$6,995.00
Antibody Partnering Terms and Agreements

Antibody Partnering Terms and Agreements

Date Published: Jan 1 2015
The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
$2,995.00
Infectious Vaccines Partnering Terms and Agreements

Infectious Vaccines Partnering Terms and Agreements

Date Published: Jan 1 2015
The Infectious Vaccines Partnering Terms and Agreements provides comprehensive understanding and unprecedented access to the infectious vaccines partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

$1,995.00
Global Prenatal and Newborn Genetic Testing Market 2015-2019

Global Prenatal and Newborn Genetic Testing Market 2015-2019

Date Published: Dec 31 2014

About Prenatal and Newborn Genetic Testing
Prenatal and newborn genetic testing involves genetic testing before and after birth. Prenatal testing helps detect changes in the fetus before birth. It can reduce a couple's uncertainty or help them decide whether to abort a pregnancy in case of conditions such as Down syndrome, trisomy 18, or an open neural tube defect. The procedure includes two blood tests: one in the first trimester and the next in the second trimester. On the other hand, newborn genetic testing is done just after birth to identify genetic disorders.

$2,500.00
Global CRO Market 2015-2019

Global CRO Market 2015-2019

Date Published: Dec 31 2014

About CRO

$2,500.00
Global Gene Expression Market 2015-2019

Global Gene Expression Market 2015-2019

Date Published: Dec 31 2014

About Gene Expression

$3,000.00
Global Healthcare and Life Sciences ITO Market 2015-2019

Global Healthcare and Life Sciences ITO Market 2015-2019

Date Published: Dec 24 2014

About Global Healthcare and Life Sciences ITO Market

$2,500.00
Global Microarray market 2015-2019

Global Microarray market 2015-2019

Date Published: Dec 24 2014

About Microarray

$2,500.00
Global Transfection Technologies Market 2015-2019

Global Transfection Technologies Market 2015-2019

Date Published: Dec 24 2014

About Transfection Technology
Transfection technology is used for the introduction of nucleic acids into desired cells. The process enables the expression of desired proteins in efficient cells. A stable transfection enables the integration of this foreign nucleic acid into the cellular DNA resulting in the expression of the desired proteins in cell lines. The process, which can be accomplished by various physical, chemical, or viral methods, can be used for potential applications such as gene therapy, protein production, and drug discovery.

$2,500.00
Global Regenerative Medicine Market 2015-2019

Global Regenerative Medicine Market 2015-2019

Date Published: Dec 17 2014

About Regenerative Medicines

$2,500.00
Global Active Pharmaceutical Ingredients Market 2015-2019

Global Active Pharmaceutical Ingredients Market 2015-2019

Date Published: Dec 10 2014

About Active Pharmaceutical Ingredients
Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis.

$3,000.00
Oncology Partnering Terms and Agreements

Oncology Partnering Terms and Agreements

Date Published: Dec 1 2014
The Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies
 

Description

The Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the oncology/cancer partnering deals and agreements entered into by the worlds leading healthcare companies.
$2,995.00
Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the royalty financing partnering agreements entered into by the worlds leading healthcare companies.

Description
The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.

$1,995.00
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.

$2,995.00
Dermatology Partnering Terms and Agreements

Dermatology Partnering Terms and Agreements

Date Published: Dec 1 2014
The Dermatology Partnering Terms and Agreementsreport provides a detailed understanding and analysis of how and why companies enter dermatology partnering deals. 
The majority of deals are marketed stage deals whereby the licensee obtains a marketing right or an option tcmarket or market the licensors dermatology product candidates. These deals tend tbe multicomponent, starting with collaborative R&D, and commercialization of outcomes. 
 
$2,995.00
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies

$3,295.00
Gene Therapy Partnering Terms and Agreements

Gene Therapy Partnering Terms and Agreements

Date Published: Dec 1 2014

The Gene Therapy Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

$1,995.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data